93 related articles for article (PubMed ID: 19631991)
1. Glucagon-like peptide-1 secretion in bulimia nervosa.
Brambilla F; Monteleone P; Maj M
Psychiatry Res; 2009 Aug; 169(1):82-5. PubMed ID: 19631991
[TBL] [Abstract][Full Text] [Related]
2. Effects of an antiandrogenic oral contraceptive on appetite and eating behavior in bulimic women.
Naessén S; Carlström K; Byström B; Pierre Y; Hirschberg AL
Psychoneuroendocrinology; 2007 Jun; 32(5):548-54. PubMed ID: 17475412
[TBL] [Abstract][Full Text] [Related]
3. Women with bulimia nervosa exhibit attenuated secretion of glucagon-like peptide 1, pancreatic polypeptide, and insulin in response to a meal.
Naessén S; Carlström K; Holst JJ; Hellström PM; Hirschberg AL
Am J Clin Nutr; 2011 Oct; 94(4):967-72. PubMed ID: 21813805
[TBL] [Abstract][Full Text] [Related]
4. Enhanced ghrelin secretion in the cephalic phase of food ingestion in women with bulimia nervosa.
Monteleone P; Serritella C; Scognamiglio P; Maj M
Psychoneuroendocrinology; 2010 Feb; 35(2):284-8. PubMed ID: 19631473
[TBL] [Abstract][Full Text] [Related]
5. Anger expression in eating disorders: clinical, psychopathological and personality correlates.
Krug I; Bulik CM; Vall-Llovera ON; Granero R; Agüera Z; Villarejo C; Jiménez-Murcia S; Fernández-Aranda F
Psychiatry Res; 2008 Nov; 161(2):195-205. PubMed ID: 18838172
[TBL] [Abstract][Full Text] [Related]
6. Preliminary examination of glucagon-like peptide-1 levels in women with purging disorder and bulimia nervosa.
Dossat AM; Bodell LP; Williams DL; Eckel LA; Keel PK
Int J Eat Disord; 2015 Mar; 48(2):199-205. PubMed ID: 24590464
[TBL] [Abstract][Full Text] [Related]
7. The Yale-Brown-Cornell eating disorder scale in women with anorexia nervosa: what is it measuring?
Jordan J; Joyce PR; Carter FA; McIntosh VV; Luty SE; McKenzie JM; Frampton CM; Bulik CM
Int J Eat Disord; 2009 Apr; 42(3):267-74. PubMed ID: 18951459
[TBL] [Abstract][Full Text] [Related]
8. No changes in serum ghrelin levels in female patients with bulimia nervosa.
Nakazato M; Hashimoto K; Shiina A; Koizumi H; Mitsumoti M; Imai M; Shimizu E; Iyo M
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Nov; 28(7):1181-4. PubMed ID: 15610931
[TBL] [Abstract][Full Text] [Related]
9. [Personality characteristics, defence mechanisms and binge eating in obese patients].
Pozzoli S; Drago C; Zanardi G; Negri M; Giorgi I
G Ital Med Lav Ergon; 2007; 29(3 Suppl B):B44-9. PubMed ID: 18575357
[TBL] [Abstract][Full Text] [Related]
10. CCK, ghrelin, and PYY responses in individuals with binge eating disorder before and after a cognitive behavioral treatment (CBT).
Munsch S; Biedert E; Meyer AH; Herpertz S; Beglinger C
Physiol Behav; 2009 Apr; 97(1):14-20. PubMed ID: 19419677
[TBL] [Abstract][Full Text] [Related]
11. Central dopaminergic function in anorexia and bulimia nervosa: a psychoneuroendocrine approach.
Brambilla F; Bellodi L; Arancio C; Ronchi P; Limonta D
Psychoneuroendocrinology; 2001 May; 26(4):393-409. PubMed ID: 11259859
[TBL] [Abstract][Full Text] [Related]
12. Relationship between plasma concentrations of cytokines, ratio of CD4 and CD8, lymphocyte proliferative responses, and depressive and anxiety state in bulimia nervosa.
Nagata T; Yamada H; Iketani T; Kiriike N
J Psychosom Res; 2006 Jan; 60(1):99-103. PubMed ID: 16380316
[TBL] [Abstract][Full Text] [Related]
13. Disgust and eating disorder symptomatology in a non-clinical population: the role of trait anxiety and anxiety sensitivity.
Davey GC; Chapman L
Clin Psychol Psychother; 2009; 16(4):268-75. PubMed ID: 19639650
[TBL] [Abstract][Full Text] [Related]
14. Modulation of thermal pain perception by stress and sweet taste in women with bulimia nervosa.
Yamamotova A; Papezova H; Uher R
Neuro Endocrinol Lett; 2009; 30(2):237-44. PubMed ID: 19675517
[TBL] [Abstract][Full Text] [Related]
15. Orally administered glucagon-like peptide-1 affects glucose homeostasis following an oral glucose tolerance test in healthy male subjects.
Steinert RE; Poller B; Castelli MC; Friedman K; Huber AR; Drewe J; Beglinger C
Clin Pharmacol Ther; 2009 Dec; 86(6):644-50. PubMed ID: 19727071
[TBL] [Abstract][Full Text] [Related]
16. [No effect of spironolactone on bulimia nervosa symptoms].
von Wietersheim J; Müller-Bock V; Rauh S; Danner B; Chrenko K; Bühler G
Psychother Psychosom Med Psychol; 2008 Dec; 58(12):470-4. PubMed ID: 18666040
[TBL] [Abstract][Full Text] [Related]
17. Screening for eating disorders in a psychiatric outpatient population.
Jauregui Lobera I; Bermudo Parra S; Martinez Lopez MD; Cuadri Galan D; Garrido Casals O; Alvarez Bautista E
Eur J Gen Pract; 2009; 15(2):107-11. PubMed ID: 19606398
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis on drugs in people with eating disorders.
Calero-Elvira A; Krug I; Davis K; López C; Fernández-Aranda F; Treasure J
Eur Eat Disord Rev; 2009 Jul; 17(4):243-59. PubMed ID: 19475697
[TBL] [Abstract][Full Text] [Related]
19. [Psychogenic determinants of bulimia nervosa].
Pilecki MW
Przegl Lek; 2009; 66(1-2):106-9. PubMed ID: 19485267
[TBL] [Abstract][Full Text] [Related]
20. Correlation of BDNF blood levels with interoceptive awareness and maturity fears in anorexia and bulimia nervosa patients.
Mercader JM; Fernández-Aranda F; Gratacòs M; Aguera Z; Forcano L; Ribasés M; Villarejo C; Estivill X
J Neural Transm (Vienna); 2010 Apr; 117(4):505-12. PubMed ID: 20195875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
